featured
GLP-1 Receptor Agonists and the Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Clinical Endocrinology and Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
J. Clin. Endocrinol. Metab. 2023 Jun 16;108(7)1806-1812, M Banerjee, R Pal, S Mukhopadhyay, K NairFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.